stockprofessors.com

Traders Recap - Sigma Labs Inc (OTCMKTS:SGLB), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Novavax, Inc (NASDAQ:NVAX), Teradyne, Inc (NYSE:TER)

 
Repost This

New York, NY -- (SBWIRE) -- 01/24/2014 -- Stock Professors is committed to provide its readers with best analytics on hot penny stocks. Our team of stock trading professional's mission is to analyze, track and rate the top penny stocks to buy in the market today. We realize how tough it is for the ordinary investor to make money in today’s volatile stock market. Some, probably like you turn to penny stocks in order to make huge gains on relatively little capital. Today’s hot Stocks to watch are: Sigma Labs Inc (OTCMKTS:SGLB), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Novavax, Inc (NASDAQ:NVAX), Teradyne, Inc (NYSE:TER)

Sigma Labs Inc (OTCMKTS:SGLB) showed a volume of 11.04 million shares by the end of last trade whereas the average volume of the stock remained 7.50 million shares. The stock opened the session at $0.16 but then moved to $0.142. At that price, the stock showed a negative performance of -7.32%. Sigma Labs, Inc. has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies,

Will SGLB Get Buyers Even After The Recent Rally? Find Out Here

Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) opened the session at $2.10 and closed the session at $2.06. The stock showed a negative performance of -5.94% in previous trading session. Traded with volume of 2.03 million shares in the prior session and the average volume of the stock remained 3.52 million shares. Ballard Power Systems Inc. (Ballard) is engaged in design, development, manufacture, sale and service of fuel cell products for a variety of applications, focusing on motive power (material handling and buses) and stationary power (back-up power and distributed generation).

Has BLDP Found The Bottom And Ready To Gain Momentum? Find Out Here

Novavax, Inc (NASDAQ:NVAX) opened the session at $6.30 and closed the session at $6.40. The stock showed a positive performance of 0.63% in previous trading session. Traded with volume of 4.66 million shares in the prior session and the average volume of the stock remained 5.95 million shares. The beta of the stock remained 2.44. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines.

Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out

Teradyne, Inc (NYSE:TER) the stock advanced 0.51% and finished the session at $19.68. Traded with volume of 8.11 million shares in the prior session and the average volume of the stock remained 3.91 million shares. The beta of the stock remained 1.70. Teradyne, Inc. is a supplier of automatic test equipment. The Company designs, develops, manufactures and sells automatic test systems and solutions used to test semiconductors.

Will TER Continue To Move Higher? Find Out Here

About Stock Professors:
We realize how tough it is for the ordinary investor to make money in today’s volatile stock market. That is why we offer penny stocks to watch and FREE stock picks to all our subscribers. We focus on undervalued and undiscovered penny stocks which are poised for not just short term but also long term growth. StockProfessors.com searches the market to bring you the best penny stocks. So, don’t wait any longer and subscribe to our FREE newsletter to get the hot penny stock picks delivered right in your email inbox!

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances.

The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://www.stockprofessors.com/disclaimer/